ADMET Prediction Compounds of Polar Extract Curcuma rhizoma
DOI:
https://doi.org/10.52622/jisk.v5i3.01Keywords:
ADMET prediction, Curcuma rhizoma, pharmacokinetics, gastrointestinal absorption, blood-brain barrier (BBB) permeability, cytochrome P450 inhibitionAbstract
The pharmacokinetic and metabolic profiles of polar extract compounds from Curcuma rhizoma were evaluated using ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) predictions. Most compounds exhibited high gastrointestinal (GI) absorption, with the exception of D-glucose, citric acid, and terpenoids such as alpha-pinene and zingiberene, which demonstrated low absorption, highlighting potential challenges for systemic bioavailability. Blood-brain barrier (BBB) permeability was observed in lipophilic compounds like xanthorrhizol, bisdemethoxycurcumin, and terpenoids, suggesting their potential for CNS-targeted therapies, while polar compounds, including D-glucose, citric acid, and most curcuminoids, were non-permeant. D-glucose was the only compound identified as a P-glycoprotein (Pgp) substrate, indicating minimal efflux-related limitations for other compounds. Selective cytochrome P450 (CYP) enzyme inhibition was detected in compounds such as xanthorrhizol, curcuminoids, and zingiberene, suggesting potential metabolic interactions in multi-drug contexts. Promising therapeutic candidates include curcuminoids and xanthorrhizol, while non-BBB-permeant and low-absorbing compounds may require formulation strategies or alternative applications. These findings provide valuable insights into the pharmacological optimization of Curcuma rhizoma compounds, offering a foundation for further research in drug discovery and development.
Downloads
References
N. Nasim, I. S. Sandeep, and S. Mohanty, “Plant-Derived Natural Products for Drug Discovery: Current Approaches and Prospects,” The Nucleus, vol. 65, no. 3, pp. 399–411, 2022, doi: 10.1007/s13237-022-00405-3.
N. S. Dosoky and W. N. Setzer, “Chemical Composition and Biological Activities of Essential Oils of Curcuma Species,” Nutrients, vol. 10, no. 9, 2018, doi: 10.3390/nu10091196.
E. Rahmat, J. Lee, and Y. Kang, “Javanese Turmeric (Curcuma xanthorrhiza Roxb.): Ethnobotany, Phytochemistry, Biotechnology, and Pharmacological Activities,” Evidence-Based Complementary and Alternative Medicine, vol. 2021, no. 1, p. 9960813, 2021, doi: 10.1155/2021/9960813.
M. Masullo, P. Montoro, A. Mari, C. Pizza, and S. Piacente, “Medicinal Plants in The Treatment of Women’s Disorders: Analytical Strategies to Assure Quality, Safety and Efficacy,” J Pharm Biomed Anal, vol. 113, pp. 189–211, 2015, doi:10.1016/j.jpba.2015.03.020.
L. Marliani, W. Budiana, Y. Anandari, S. Tinggi, and F. Bandung, “The effect of Extraction Condition on the Polyphenol Content and Antioxidant Activity of Curcuma zedoaria (Christm.) Roscoe Rhizome,” 2017.
A. Budiansyah, U. Haroen, S. Syafwan, and K. Kurniawan, “Antioxidant and Antibacterial Activities of The Rhizome Extract of Curcuma zedoaria Extracted Using Some Organic Solvents,” J Adv Vet Anim Res, vol. 10, no. 3, pp. 347–360, Sep. 2023, doi: 10.5455/javar.2023.j687.
G. Biala et al., “Research in The Field of Drug Design and Development,” Pharmaceuticals, vol. 16, no. 9, 2023, doi: 10.3390/ph16091283.
N. Singh, P. Vayer, S. Tanwar, J.-L. Poyet, K. Tsaioun, and B. O. Villoutreix, “Drug Discovery and Development: Introduction to The General Public and Patient Groups,” Frontiers in Drug Discovery, vol. 3, 2023, doi: 10.3389/fddsv.2023.1201419.
B. Chandrasekaran, S. N. Abed, O. Al-Attraqchi, K. Kuche, and R. K. Tekade, “Chapter 21 - Computer-Aided Prediction of Pharmacokinetic (ADMET) Properties,” in Dosage Form Design Parameters, R. K. Tekade, Ed., in Advances in Pharmaceutical Product Development and Research. Academic Press, 2018, pp. 731–755. doi: 10.1016/B978-0-12-814421-3.00021-X.
J. Dulsat, B. López-Nieto, R. Estrada-Tejedor, and J. I. Borrell, “Evaluation of Free Online ADMET Tools for Academic or Small Biotech Environments,” Molecules, vol. 28, no. 2, 2023, doi: 10.3390/molecules28020776.
F. Wu et al., “Computational Approaches in Preclinical Studies on Drug Discovery and Development,” Front Chem, vol. 8, 2020, doi: 10.3389/fchem.2020.00726.
A. Daina, O. Michielin, and V. Zoete, “SwissADME: a Free Web Tool to Evaluate Pharmacokinetics, Drug-Likeness and Medicinal Chemistry Friendliness of Small Molecules,” Sci Rep, vol. 7, no. 1, p. 42717, 2017, doi: 10.1038/srep42717.
A. Simamora et al., “Ultrasonic-Assisted Extraction of Xanthorrhizol from Curcuma xanthorrhiza Roxb. Rhizomes by Natural Deep Eutectic Solvents: Optimization, Antioxidant Activity, and Toxicity Profiles,” Molecules, vol. 29, no. 9, 2024, doi: 10.3390/molecules29092093.
A. Simamora, K. H. Timotius, H. Setiawan, M. Y. Putra, and A. Munim, “Natural Deep Eutectic Solvent Extraction of Xanthorrhizol and Curcuminoids from Curcuma xanthorrhiza Roxb and Simultaneous Determination by High-Performance Liquid Chromatography,” J Pharm Pharmacogn Res, vol. 11, no. 6, pp. 1056–1071, Nov. 2023, doi: 10.56499/jppres23.1727_11.6.1056.
E. Książek, “Citric Acid: Properties, Microbial Production, and Applications in Industries,” Molecules, vol. 29, no. 1, 2024, doi: 10.3390/molecules29010022.
P. Zhang et al., “Maternal Consumption of l-malic Acid Enriched Diets Improves Antioxidant Capacity and Glucose Metabolism in offspring by Regulating The Gut Microbiota,” Redox Biol, vol. 67, p. 102889, 2023, doi:10.1016/j.redox.2023.102889.
E. Dermawaty D, “Potential Extract Curcuma (Curcuma xanthorrizal Roxb) As Antibacterial,” Majority, pp. 4, 5–11, 2015.
S. Paul and G. Sa, “Curcumin as An Adjuvant to Cancer Immunotherapy,” Aug. 16, 2021, Frontiers Media S.A. doi: 10.3389/fonc.2021.675923.
G. K. Jayaprakasha, L. Jaganmohan Rao, and K. K. Sakariah, “Antioxidant Activities of Curcumin, Demethoxycurcumin and Bisdemethoxycurcumin,” Food Chem, vol. 98, no. 4, pp. 720–724, 2006, doi: 10.1016/j.foodchem.2005.06.037.
B. Salehi et al., “Therapeutic Potential of α- and β-Pinene: A Miracle Gift of Nature,” Biomolecules, vol. 9, no. 11, 2019, doi: 10.3390/biom9110738.
Yuandani et al., “Immunomodulatory Effects and Mechanisms of The Extracts and Secondary Compounds of Zingiber and Alpinia Species: A Review,” Front Pharmacol, vol. 14, 2023, doi: 10.3389/fphar.2023.1222195.
C. Stillhart et al., “Impact of Gastrointestinal Physiology on Drug Absorption in Special Populations––An Ungap Review,” European Journal of Pharmaceutical Sciences, vol. 147, p. 105280, 2020, doi: 10.1016/j.ejps.2020.105280.
P. B. Shekhawat and V. B. Pokharkar, “Understanding Peroral Absorption: Regulatory Aspects and Contemporary Approaches to Tackling Solubility and Permeability Hurdles,” Acta Pharm Sin B, vol. 7, no. 3, pp. 260–280, 2017, doi: 10.1016/j.apsb.2016.09.005.
P. R. Kiela and F. K. Ghishan, “Physiology of Intestinal Absorption and Secretion,” Best Pract Res Clin Gastroenterol, vol. 30, no. 2, pp. 145–159, 2016, doi: 10.1016/j.bpg.2016.02.007.
A. Alahmari, “Blood-Brain Barrier Overview: Structural and Functional Correlation,” Neural Plast, vol. 2021, no. 1, p. 6564585, 2021, doi: 10.1155/2021/6564585.
A. Monroy, G. J. Lithgow, and S. Alavez, “Curcumin and Neurodegenerative Diseases,” BioFactors, vol. 39, no. 1, pp. 122–132, 2013, doi: 10.1002/biof.1063.
M. Hosseini, M. H. Boskabady, and M. R. khazdair, “Neuroprotective Effects of Coriandrum sativum and Its Constituent, Linalool: A Review,” Avicenna J Phytomed, vol. 11, no. 5, pp. 436–450, 2021, doi: 10.22038/ajp.2021.55681.2786.
M. Elmeliegy, M. Vourvahis, C. Guo, and D. D. Wang, “Effect of P-glycoprotein (P-gp) Inducers on Exposure of P-gp Substrates: Review of Clinical Drug–Drug Interaction Studies,” Clin Pharmacokinet, vol. 59, no. 6, pp. 699–714, 2020, doi: 10.1007/s40262-020-00867-1.
Y.-J. Kwon, S. Shin, and Y.-J. Chun, “Biological Roles of Cytochrome P450 1A1, 1A2, and 1B1 Enzymes,” Arch Pharm Res, vol. 44, no. 1, pp. 63–83, 2021, doi: 10.1007/s12272-021-01306-w.
Q. Shubbar, A. Alchakee, K. W. Issa, A. J. Adi, A. I. Shorbagi, and M. Saber-Ayad, “From Genes to Drugs: CYP2C19 and Pharmacogenetics in Clinical Practice,” Front Pharmacol, vol. 15, 2024, doi: 10.3389/fphar.2024.1326776.
A. Ramamoorthy, T. Sissung, and M. Pacanowski, “Chapter 12 - Clinical Pharmacogenetics,” in Atkinson’s Principles of Clinical Pharmacology (Fourth Edition), Fourth Edition., S.-M. Huang, J. J. L. Lertora, P. Vicini, and A. J. Atkinson, Eds., Boston: Academic Press, 2022, pp. 189–212. doi: 10.1016/B978-0-12-819869-8.00016-1.
E. J. Cicali, D. M. Smith, B. Q. Duong, L. G. Kovar, L. H. Cavallari, and J. A. Johnson, “A Scoping Review of the Evidence Behind Cytochrome P450 2D6 Isoenzyme Inhibitor Classifications,” Clin Pharmacol Ther, vol. 108, no. 1, pp. 116–125, 2020, doi: 10.1002/cpt.1768.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Jurnal Indah Sains dan Klinis
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This work is licensed under a 
